GGrantIndex
Sort

23,748 grants matching melanoma

Detection of Melanoma by Canine Olfactory Receptors.

$206,550
Tatjana Abaffy · University Of Miami School Of Medicine · R21 · FY2008 · CA

Core C: Biostatistics and Bioinformatics Core

$206,456
Shuangge Ma · Yale University · P50 · FY2023 · CA

Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)

$206,400
Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · UG1 · FY2023 · HL

MIEDZYNARODOWY INSTYTUT ONKOLOGII MOLEKULARNEJ:1268477 [16-013238]Tissue Source Site (TSS) Clinical Proteomics Tumor Analysis Consortium (CPTAC)This modification is to add and exercise an option f

$206,400
Maciej Wiznerowicz · Internat'L Institute/Molecular Oncology · N02 · FY2017 · CA

Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)

$206,400
Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · UG1 · FY2020 · HL

Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)

$206,400
Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · UG1 · FY2021 · HL

Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)

$206,400
Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · UG1 · FY2022 · HL

Core Clinical Centers for the Blood and Marrow Transplant Clinical Trials Network (UG1)

$206,400
Joseph A Pidala · H. Lee Moffitt Cancer Ctr & Res Inst · UG1 · FY2019 · HL

UV-induced and NOS-mediated Zn elevation, translation regulatin and apoptosis.

$206,388
Shiyong Wu · Ohio University Athens · R56 · FY2007 · CA

Chemical biology of superstolides--a novel class of anticancer natural products

$206,296
Zhendong Jin · University Of Iowa · R21 · FY2016 · CA

Adaptive signaling exposes a therapeutic vulnerability in NRAS melanomas

$206,190
Michael J Weber · University Of Virginia · R21 · FY2014 · CA

PQ3: Age-related immune deviation and cancer outcome

$206,190
Holden T. Maecker · Stanford University · R21 · FY2017 · CA

Two phospho-compounds for pancreatic cancer prevention

$206,190
Gerardo Guillermo Mackenzie · State University New York Stony Brook · R21 · FY2015 · CA

Novel Micro/nanofluidic Electroporation Devices for DNA&Oligonucleotide Delivery

$206,173
Ly James Lee · Ohio State University · R21 · FY2008 · EB

ACTIVATION OF TYROSINASE IN HUMAN MELANOGENESIS

$206,150
Boston University Medical Campus · R01 · FY2000 · CA

Studies on Lineage Plasticity in Prostate Cancer

$205,990
Samir Zaidi · Sloan-Kettering Inst Can Research · K08 · FY2024 · CA

IMMUNODERMATOLOGICAL THERAPY OF SKIN CANCER

$205,934
University Of Alabama At Birmingham · R01 · FY2001 · CA

INTEGRIN ASSOCIATED PROTEIN IS A THROMBOSPONDIN RECEPTOR

$205,906
Washington University · R01 · FY2000 · GM

DNA repair dysfunction in cancer induced by altered BRCA2 localization

$205,848
Judit Jimenez Sainz · Medical University Of South Carolina · K22 · FY2025 · CA

DNA repair dysfunction in cancer induced by altered BRCA2 localization

$205,848
Judit Jimenez Sainz · Medical University Of South Carolina · K22 · FY2023 · CA

DNA repair dysfunction in cancer induced by altered BRCA2 localization

$205,848
Judit Jimenez Sainz · Medical University Of South Carolina · K22 · FY2024 · CA

TRANSCRIPTION FACTOR AP2 IN METASTASIS OF MELANOMA

$205,837
University Of Texas Md Anderson Can Ctr · R01 · FY2000 · CA

(PQ8) Biomarker identification by mass cytometry in peripheral blood of patients with renal cell carcinoma undergoing immune checkpoint therapy

$205,799
Wendy Jane Fantl · Stanford University · R21 · FY2019 · CA

PD-1 Blockade and Neoantigen-Specific T Cell Immunity

$205,782
Gerald P Linette · University Of Pennsylvania · R21 · FY2016 · CA

INVASIVE BEHAVIOR OF TUMOR CELLS PRODUCING COLLAGENASE

$205,767
Dartmouth College · R01 · FY2000 · CA